Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07098169 · ClinicalTrials.gov registry record · NA
Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
A NA study of Schizoaffective Disorder and Schizophrenia Disorders, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- NA
- Development phase
- 201
- Enrollment target
- 3
- Study locations
NCT07098169 is a NA study of Schizoaffective Disorder and Schizophrenia Disorders that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 201 participants, roughly in line with the 199-participant average among 81 other Schizoaffective Disorder trials with a reported enrollment target. The trial reports 3 study locations across 3 states.
The verdict
NCT07098169, a NA study of Schizoaffective Disorder and Schizophrenia Disorders, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- NA
- Development phase
- 201 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to evaluate the effectiveness of a psychosocial intervention called iTEST for people with psychotic disorders that targets introspective accuracy, or the ability to accurately gauge ones abilities. iTEST combines daily cognitive training on a mobile device with coaching that addresses recovery goals. In this trial, we will randomize people to one of two interventions conditions, iTEST or a control condition that receives coaching and cognitive training that does not emphasize introspective accuracy. Both interventions will take place over 12 weeks and participants will be asked to complete assessments at baseline, 6 weeks, 12 weeks, and 24 weeks. The primary outcome of the study is community functioning. Participants will be from three metropolitan areas: San Diego, Dallas, or Miami.
Conditions Studied
Interventions
- BEHAVIORAL Active Control
- BEHAVIORAL iTEST
Study Locations (3)
California
- UC San Diego - San Diego
Florida
- University of Miami - Miami
Texas
- University of Texas at Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2028-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07098169
The ClinicalTrials.gov registry entry for NCT07098169 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 199-participant average among 81 other Schizoaffective Disorder trials with a reported enrollment target. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Schizoaffective Disorder appearing as the primary indexed condition, and to 2 interventions - of which Active Control is the first listed.
NCT07098169 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Florida, Texas.
Frequently Asked Questions
What is clinical trial NCT07098169 about?
NCT07098169 is a clinical study titled "Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy". The purpose of this study is to evaluate the effectiveness of a psychosocial intervention called iTEST for people with psychotic disorders that targets introspective accuracy, or the ability to accurately gauge ones abilities. iTEST combines daily cognitive training on a mobile device with coaching ...
What is the current status of trial NCT07098169?
This trial is currently recruiting. It is a NA study. The enrollment target is 201 participants. The study started on 2025-09-01. Estimated completion is 2028-04-01.
What conditions does trial NCT07098169 study?
This clinical trial studies the following conditions: Schizoaffective Disorder, Schizophrenia Disorders, Psychotic Disorder.
What interventions are being tested in trial NCT07098169?
The interventions under investigation include: Active Control (BEHAVIORAL), iTEST (BEHAVIORAL).
Who is sponsoring clinical trial NCT07098169?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07098169 being conducted?
This trial has 3 study locations across California, Florida, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizoaffective Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study
RECRUITING · NA
-
Effectiveness of Motivation Skills Training (MST)
RECRUITING · NA
-
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
RECRUITING · NA
-
Prebiotic Treatment in People With Schizophrenia
RECRUITING · NA
-
Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.